Eon Sporanox Generic Cleared To Launch By Court
This article was originally published in The Pink Sheet Daily
Executive Summary
The company is reviewing a trial court’s ruling that it does not infringe a Janssen patent before deciding whether to launch. Eon says its 180-day exclusivity will not be triggered until commercial marketing or an appellate court decision.